Home » Topics » Regulatory

Regulatory
RSS

FDA approves Bayer's Xarelto for new indication

Nov. 7, 2011

FDA approves Pacira Pharmaceuticals' Exparel

Nov. 2, 2011

European Commission extends Alimta approval

Oct. 28, 2011

European indication of Prevenar 13 extended

Oct. 28, 2011

FDA approves adjunctive therapy for Lennox-Gastaut syndrome

Oct. 25, 2011

FDA approves new indication for Byetta

Oct. 20, 2011

FDA approves Merck & Co.'s Juvisync

Oct. 10, 2011

FDA approves Lilly's Cialis for new indications

Oct. 7, 2011

Pfizer launches BeneFIX RTS in Europe

Oct. 4, 2011

Mucosta approved in Japan for dry eye syndrome

Sep. 27, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...